(Press-News.org) Interim data from a phase 3 trial of a COVID-19 vaccine developed in China (CoronaVac) suggests that two doses offer 83.5% protection against symptomatic COVID-19.
The preliminary findings, published in The Lancet and presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), indicate that CoronaVac induces a robust antibody response. No severe adverse events or deaths were reported among the more than 10,000 trial participants in Turkey, with most adverse events mild and occurring within 7 days of an injection. However, more research is needed to confirm vaccine efficacy in the long term, in a more diverse group of participants, and against emerging variants of concern.
CoronaVac uses an inactivated whole virus. When people receive the vaccine, their immune system attacks the harmless form of the virus by producing antibodies to fight it off, leading to immunity. Developed by Sinovac Life Sciences, the vaccine - which can be stored and transported at 2-8°C - has been approved for emergency use in 22 countries, and has been in phase 3 trials since mid-2020 in Brazil, Indonesia, Chile, and Turkey. In this trial, participants were given two 3μg doses of CoronaVac 14 days apart.
To date, interim efficacy and safety results of phase 3 trials have been reported for 8 COVID-19 vaccines: University of Oxford/AstraZeneca, Gam-COVID-Vac, Moderna, Pfizer, Janssen, Novavax, and two inactivated vaccines developed by Sinopharm. [1]
Lead author Professor Murat Akova, from Hacettepe University Medical School, Turkey, said: "In order to bring the COVID-19 pandemic under control, the world needs every single dose of safe and effective vaccines, and our results add important evidence of the safety and effectiveness of inactivated-virus vaccines. One of the advantages of CoronaVac is that it does not need to be frozen, making it easier to transport and distribute. This could be particularly important for global distribution, as some countries may struggle to store large amounts of vaccine at very low temperatures." [2]
Between September 14, 2020, and January 5, 2021, 10,218 adults between 18 and 59 years were randomly assigned to receive two doses of the vaccine (6,650) or a placebo (3,568). The trial was conducted across 24 centres in Turkey. The average age of the participants was 45 years and 5,907 (58%) were male.
After the first dose, 87 participants in the vaccine group and 98 in the placebo group were excluded. The most common reasons for exclusion in the vaccine group were returning a positive COVID-19 test (60) and withdrawing from the study (11). The most common reasons in the placebo arm were unblinding before the second dose (45) and returning a positive COVID-19 test (35). A further 4 participants in the vaccine group were excluded after the second dose as they were aged over 59 years.
In total, 10,029 participants (6,559 in the vaccine group and 3,470 in the placebo group) were included in the efficacy analysis, and 10,214 participants (not including the 4 excluded who were over 59 years) were included in the safety analysis.
In total, 150 COVID-19 cases were confirmed by PCR after an average follow-up of 43 days, an incidence rate of 123 cases per 1,000 people per year. From 14 days after the second dose, 9 cases of symptomatic COVID-19 were confirmed in the vaccine group, an incidence rate of 32 cases per 1,000 people per year. In the placebo group, 32 cases were reported, an incidence rate of 192 cases per 1,000 people per year. Following analysis, the authors estimate that this is equivalent to a vaccine efficacy of 83.5%.
Analysis of immune responses induced by the vaccine involved a sample of 1,413 participants (981 from the vaccine group and 432 from the placebo group). CoronaVac induced an antibody response among 90% (880/981) of those who received the vaccine. The authors note that antibody response decreased with increasing age in men and women.
Adverse reactions were analysed using data from 10,214 participants (6,646 in the vaccine group and 3,568 in the placebo group). The incidence of adverse events in those who received the vaccine was relatively low at 19% (1,259/6,646). The incidence in the placebo group was 17% (603/3,568).
A total of 3,845 adverse effects were reported in 1,862 participants. Most of the reported adverse effects (90% [3,469/3,845]) were mild, and included fatigue, pain at the injection site, and myalgia. No severe adverse events or fatalities were recorded during the study period, and only 6 participants ( END
The Lancet: CoronaVac COVID-19 vaccine is safe and protects against disease, interim analysis
2021-07-09
ELSE PRESS RELEASES FROM THIS DATE:
Nearly 8% of men who have sex with men estimated to have syphilis globally
2021-07-09
Led by the London School of Hygiene & Tropical Medicine (LSHTM), in partnership with the World Health Organization (WHO) and Avenir Health, the research team carried out a systematic review and meta-analysis of syphilis prevalence among MSM between 2000 to 2020, drawing on data from 275 studies involving more than 600,000 study participants across 77 countries.
The worldwide prevalence of syphilis among MSM was 15x higher than most recent estimates for men in the general population (7.5% versus 0.5%). Researchers further estimated the prevalence across eight regions of the Sustainable Development Goals (SDG) and six regions of the WHO. Latin America and the Caribbean region had the highest prevalence of syphilis (10.6%), whereas Australia and New Zealand had the lowest (1.9%). ...
FEWSION: Creating more resilient supply chains through nature-inspired design
2021-07-09
A new paper in Nature lays out the way natural ecosystems parallel U.S. supply chains and how American cities can use these tools to strengthen their supply chains.
The paper, "Supply chain diversity buffers cities against food shocks," is co-authored by Benjamin Ruddell, director of the FEWSION Project and the School of Informatics, Computing, and Cyber Systems at Northern Arizona University, and Richard Rushforth, an assistant research professor in SICCS, in collaboration with FEWSION project researchers at Penn State. FEWSION is an NSF-funded collaboration that uses comprehensive data mapping to monitor domestic supply chains for food, water and energy down to the county level.
This research looks at the importance of diversity within the ...
Obscuring the truth can promote cooperation
2021-07-09
Remember Napster? The peer-to-peer file sharing company, popular in the late 1990s and early 2000s, depended on users sharing their music files. To promote cooperation, such software "could mislead its users," says Bryce Morsky, a postdoc in Penn's School of Arts & Sciences.
Some file-sharing companies falsely asserted that all of their users were sharing. Or, they displayed the mean number of files shared per user, hiding the fact that some users were sharing a great deal and many others were not. Related online forums promoted the idea that sharing was both ethical and the norm. ...
Ecologists compare accuracy of lidar technologies for monitoring forest vegetation
2021-07-09
As light detection and ranging (lidar) technology evolves, forest ecology and ecological restoration researchers have been using these tools in a wide range of applications.
"We needed an accounting of relative accuracy and errors among lidar platforms within a range of forest types and structural configurations," said associate professor Andrew Sánchez Meador, executive director of NAU's Ecological Restoration Institute (ERI).
Sánchez Meador led a study recently published in Remote Sensing, "Adjudicating Perspectives on Forest Structure: How Do Airborne, ...
Longest known continuous record of the Paleozoic discovered in Yukon wilderness
2021-07-09
Hundreds of millions of years ago, in the middle of what would eventually become Canada's Yukon Territory, an ocean swirled with armored trilobites, clam-like brachiopods and soft, squishy creatures akin to slugs and squid.
A trove of fossils and rock layers formed on that ancient ocean floor have now been unearthed by an international team of scientists along the banks of the Peel River a few hundred miles south of the Arctic's Beaufort Sea. The discovery reveals oxygen changes at the seafloor across nearly 120 million years of the early Paleozoic era, a time that fostered the most rapid development and diversification of complex, multi-cellular life in Earth's history.
"It's unheard of to have that much of Earth's history in one place," said Stanford University geological ...
Our genes shape our gut bacteria, new research shows
2021-07-08
Our gut microbiome -- the ever-changing "rainforest" of bacteria living in our intestines -- is primarily affected by our lifestyle, including what we eat or the medications we take, most studies show.
But a University of Notre Dame study has found a much greater genetic component at play than was once known.
In the study, published recently in END ...
Many nonprofits, companies report using commercial species in tree planting projects
2021-07-08
Nonprofits and companies planting trees in the tropics may often pick species for their commercial rather than ecological value, researchers found in a new analysis of organizations' publicly available data. They also found many may not have tracked the trees' survival.
Tree planting is a promising, but controversial, restoration strategy for fighting climate change. A new study in the journal Biological Conservation provides a detailed look at what restoration organizations across the tropics are actually doing on the ground.
"We found some organizations placed an emphasis on biological diversity and forest restoration in their mission statements. When we looked at the species they reported ...
When resistance is futile, new paper advises RAD range of conservation options
2021-07-08
Major ecosystem changes like sea-level rise, desertification and lake warming are fueling uncertainty about the future. Many initiatives - such as those fighting to fully eradicate non-native species, or to combat wildfires - focus on actively resisting change to preserve a slice of the past.
However, resisting ecosystem transformation is not always a feasible approach. According to a new paper published today in the Ecological Society of America's journal Frontiers in Ecology and the Environment, accepting and directing ecosystem change are also viable responses, and should not necessarily be viewed as fallback options or as last resorts. The paper presents a set of guiding principles for applying a "RAD" strategy - a framework that involves ...
Study: How a large cat deity helps people to share space with leopards in India
2021-07-08
BENGALURU, India (July 8, 2021) - A new study led by WCS-India documents how a big cat deity worshipped by Indigenous Peoples facilitates coexistence between humans and leopards.
The study, published in a special issue of the journal Frontiers in Conservation Science: Human-Wildlife Dynamics called Understanding Coexistence with Wildlife documents how the Indigenous Warli people of Maharashtra, India, worship Waghoba, a leopard/tiger deity to gain protection from leopards, and how they have lived side-by-side with them for centuries (formerly tigers, too). The researchers have identified over 150 shrines dedicated ...
Imaging test may predict patients most at risk of some heart complications from COVID-19
2021-07-08
Researchers at Johns Hopkins Medicine have shown that a type of echocardiogram, a common test to evaluate whether a person's heart is pumping properly, may be useful in predicting which patients with COVID-19 are most at risk of developing atrial fibrillation -- an irregular heartbeat that can increase a person's risk for heart failure and stroke, among other heart issues. The new findings, END ...